Immunovant, Inc. (IMVT) earnings
Quarterly results of Immunovant, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Immunovant, Inc. is expected to report around February 5, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Latest quarter: Q2 FY2027
In Q2 FY2027 (ended September 30, 2026) Immunovant, Inc. reported revenue of - and a net loss of $97.2M.
Diluted earnings per share were -$0.47.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2027 | - | - | -$97.2M | -$0.47 |
| Q1 FY2027 | - | - | -$153.2M | -$0.75 |
| Q4 FY2026 | - | - | -$147.9M | - |
| Q3 FY2026 | - | - | -$110.6M | -$0.61 |
| Q2 FY2026 | - | - | -$126.5M | -$0.73 |
| Q1 FY2026 | - | - | -$120.6M | -$0.71 |
| Q4 FY2025 | - | - | -$106.4M | - |
| Q3 FY2025 | - | - | -$111.1M | -$0.76 |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
- Annual report 10-K
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
When is Immunovant, Inc.'s next earnings date?
Immunovant, Inc. is expected to report around February 5, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Get an email when IMVT reports
Follow IMVT and we email you its next results the day they are filed, with the numbers explained.